Emergent BioSolutions IncAdd to My Watchlist

EBS:USNew YorkIndustry: Medical-Biomedical/Gene
  • 33.00
  • 0.07  0.21%
    Today's Change
  • 32.93
    Previous Close
  • Today
    52 Week Low - High
8:04 pm ET 8/4/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding38 million
Market Cap$1 billion
Return on Equity ttm6.98%
Last DividendEBS:US does not pay a dividend
EPS: Year Actual ttm0.814
EPS: Year Est. 12/15 ttm1.407
EPS: Quarterly Actual 3/15 -0.50
EPS: Quarterly Est. 6/15 0.18
Price/Earnings ttm40.52
Relative Price/Earnings--
Earnings Growth Rate13.95
Company Description
Emergent BioSolutions, Inc. develops and produces immunobiotics, pharmaceutical products that assist the body's immune system to prevent or treat disease. The Company produces a vaccine for anthrax.
Revenue$450 million
Net Income$37 million
Total Assets$945 million
Web Sitewww.emergentbiosolutions.com

Latest Headlines


Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now


Not Registered?

Get complete access to The Washington Post online - it's FREE!